TL;DR
This multi-center study found that children with Autism Spectrum Disorder (ASD) have lower serum folate levels than typically developing children. Crucially, serum folate status was primarily linked to neurodevelopmental outcomes, particularly in children aged three and under, suggesting that adequate folate intake in early life may be beneficial for cognitive development in ASD.
What Problem Does This Paper Address?
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition with a rising prevalence. While folate, a crucial B vitamin for brain development, has been implicated in ASD, previous research has yielded inconsistent findings. These inconsistencies are often attributed to small sample sizes, a lack of age-specific analysis, and variations in assessment methods. This paper aims to address these limitations by conducting a large-scale, multi-center study to investigate the association between serum folate levels and both core ASD symptoms and neurodevelopmental outcomes, with a specific focus on age stratification, particularly in the critical early developmental period.
Methods
The study employed a case-control design, recruiting 1,300 children diagnosed with ASD and 1,246 typically developing (TD) children, all under 7 years old, from 13 cities across China. Serum folate levels were measured using automated chemiluminescence immunoassay. To assess ASD symptoms, researchers utilized the Autism Behavior Checklist (ABC), Social Responsiveness Scale (SRS), and Childhood Autism Rating Scale (CARS). Neurodevelopmental status was evaluated using the China Neuropsychological and Behavior Scale-Revision 2016 (CNBS-R2016). Statistical analyses included Kolmogorov-Smirnov tests for normality, Chi-Square tests, Mann-Whitney tests, Kruskal-Wallis tests, and both univariate and multivariate linear regression models to compare folate levels between groups and assess associations. Spearman correlation analysis was used to explore relationships within age-stratified ASD groups.
Datasets
The study utilized data from 2,546 children (1,300 ASD, 1,246 TD) recruited from 13 cities in China. This represents a significant multi-center dataset for ASD research. The study did not introduce new benchmark datasets but rather collected and analyzed data from a diverse population.
Key Insights and Ideas
- Early Life Folate Matters Most: The most striking finding is that serum folate levels are primarily associated with neurodevelopmental outcomes in children aged three and under. This highlights the critical window of early development for folate's impact.
- Folate and Cognition, Not Just Symptoms: While folate levels didn't strongly correlate with core ASD symptom severity (as measured by ABC, SRS, CARS), they showed significant positive associations with various developmental quotients (gross motor, fine motor, language, general) in the youngest age group. This suggests folate's role might be more in supporting foundational cognitive development rather than directly mitigating ASD symptom intensity.
- Higher Folate, Better Outcomes (in Early Years): When children aged three and under were divided by their median serum folate level, those with higher levels (>14.33 ng/mL) demonstrated better performance across multiple developmental domains, including gross motor, fine motor, language, and social-emotional skills, and had lower communication warning behavior scores. This provides evidence that adequate, or even higher, folate levels may be beneficial for optimal neurodevelopment in this vulnerable population.
- Dietary Link: The study observed that children with ASD who exhibited resistance to vegetables had lower serum folate levels, suggesting a potential link between dietary intake patterns and folate status in this population.
Key Results
- Children with ASD had significantly lower serum folate levels compared to TD children, even after adjusting for age and gender.
- Serum folate levels were not associated with the Autism Behavior Checklist (ABC), Social Responsiveness Scale (SRS), or Childhood Autism Rating Scale (CARS) scores in ASD children across all age groups.
- However, serum folate was negatively associated with communication warning behavior scores from the CNBS-R2016 in ASD children aged three and under.
- In ASD children aged three and under, serum folate levels were positively associated with general quotient, gross motor quotient, fine motor quotient, and language quotient.
- Children with ASD aged three and under and moderate to severe developmental delays had lower serum folate levels compared to those with no or mild developmental delays.
- Children with ASD aged three and under with serum folate levels above the median (14.33 ng/mL) showed significantly better scores in gross motor, fine motor, adaptive behavior, language, and personal-social domains compared to those with levels at or below the median.
Limitations and Future Work
The authors acknowledge several limitations:
- Age and Gender Matching: The study did not perfectly match participants for age and gender between the ASD and TD groups.
- Peripheral vs. Central Folate: Blood folate levels may not perfectly reflect folate status in the brain, as transport mechanisms and potential folate receptor auto-antibodies can influence central folate levels. The study lacked indicators for central folate status.
- Cross-Sectional Design: The study's cross-sectional nature prevents definitive causal conclusions.
Future work should include prospective, randomized controlled trials to investigate the effects of folic acid supplementation on ASD symptoms and neurodevelopment. Further research is also needed to establish specific, age-appropriate reference values for serum folate in children and to elucidate the precise mechanisms by which folate influences neurodevelopment in ASD.
Summary updated